The Green Rush 
Doug Drysdale, CEO of Cybin, Inc.
by Nick Opich on April 15, 2021 in podcast
Podcast: Play in new window | Download
Podcast: Play in new window | Download
Doug Drysdale, CEO of Cybin Inc., a leading biotechnology company focused on progressing psychedelic therapeutics to treat psychiatric disorders utilizing proprietary drug discovery platforms, innovative delivery systems, and novel formulations and treatment regiments, is this week’s special guest on the Green Rush!
Our hosts Anne and Nick sat down with Doug to talk about all things Cybin including the Company’s recent listing on the NEO exchange, its partnerships with Catalent and Kernel, its expanding IP portfolio as well as its growth and expansion plans for 2021 and beyond. In addition, we look at the future of regulations for the psychedelic space, when clinical data may become available and the similarities and differences between psychedelics and cannabis for investors.
Cybin is one of the most exciting companies in the nascent psychedelics space and it was a real treat to chat with Doug and get an in-depth look at how the company is differentiating itself from its competitors.
Don’t sit back, lean forward and enjoy!
Doug Drysdale, CEO of Cybin, Inc.
Doug Drysldale has chaired the Board of a NASDAQ-listed company and, as CEO for the past 12 years, has built and turned-around 3 pharmaceutical companies. During Doug’s 30 years of experience in the healthcare sector, he has formed cohesive management teams, recruited board members, completed 15 corporate acquisitions across three continents and has raised $4 billion of both public and private capital. Doug holds a bachelor’s degree in Microbial and Molecular Biology from the University of East Anglia in the United Kingdom and was recognized as Entrepreneur of the Year by Ernst and Young in 2012.
Links and mentions in the show
- Cybin website: https://www.cybin.com/
- Cybin X Kernel: https://www.cybin.com/kernel
- Cybin X Catalent: https://www.catalent.com/catalent-news/catalent-signs-drug-development-agreement-with-cybin-inc-for-its-fast-dissolve-formulation-of-novel-deuterated-tryptamine-cyb003/
Links to the guest’s company and social media accounts
- Cybin’s Twitter: https://twitter.com/CybinInc
- Cybin’s Instagram: https://www.instagram.com/cybininc/
- Cybin’s LinkedIn: https://www.linkedin.com/company/cybin/
- Doug’s LinkedIn: https://www.linkedin.com/in/dougdrysdale/
Show Credits:
This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.
Special thanks to our Program Director Shea Gunther.
You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:
Twitter: @The_GreenRush
Instagram: @thegreenrush_podcast
LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/
Facebook: https://www.facebook.com/TheGreenRushPodcast/
YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true
More Episodes
Frank Perullo, Co-Founder & Strategic Advisor at Ascend Wellness Holdings
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Kris Kane and Anne Donohoe return for a new episode with special guest Frank Perullo, Co-Founder and Strategic Advisor at Ascend Wellness Holdings ($AAWH). Frank joins us this week […]
Nathan Bryson, PhD, Chief Scientific Officer of Reunion Neuroscience
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Lewis Goldberg and Anne Donohoe are back for a new episode with special guest Nathan Bryson, PhD, Chief Scientific Officer of Reunion Neuroscience. Nathan joins us this week to […]
Len May, CEO and Co-Founder of Endocanna Health
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Phil Carlson return for a new episode with special guest Len May, CEO and Co-Founder of Endocanna Health. Len joins us this week to share how […]
Adam Smith, Founder of Alliance for Sensible Markets
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Kris Krane are back for a new episode with special guest Adam Smith, Founder of Alliance for Sensible Markets. Adam joined us this week to talk […]
